Cholera Diagnostic & Treatment Market

Global Cholera Diagnostic & Treatment Market: Global Size, Trends, Competitive, and Historical & Forecast Analysis, 2024-2030: Frequent growth is observed in the market due to the increasing outbreaks of cholera in recent years and rising awareness of immunization. This has resulted in a higher demand for vaccines, driving market growth.

Global Cholera Diagnostic & Treatment Market is valued at USD 4.2 Billion in 2023 and it is expected to reach USD 6.9 Billion by 2030 with a CAGR of 7.3% over the forecast period.

Scope of Global Cholera Diagnostic & Treatment Market Report:

Cholera is the acute intestinal infection caused by bacteria vibrio cholerae, which is generally spread through the food & water contaminated by species bacteria v cholera, and results in symptoms like vomiting of clear fluid & watery diarrhea. History of cholera have back to ancient times, however the outbreak of cholera in ancient time are unknown, and cholera was become known when its 7 consecutive pandemics killed millions of people in 19^th century when it spread across the world originating from Ganges delta in India.

Cholera is infectious disease: if remains untreated it causes massive dehydration, electrolyte imbalance & metabolic acidosis which further lead to the death of the person. However today there are various diagnosis & treatment options are available in the market, such as rapid diagnostic test kits, vaccines, pharmacotherapy products such as ORS, antibiotics, intravenous fluids. These products are made to treat & diagnose cholera used by doctors as well as patients.

Many countries are witnessing outbreak of the cholera in last few years, however treatment & diagnostic product of cholera are evaluating every year, various companies inventing the products in cholera market and generating the revenue through selling them. While both doctors & patients are served as end users of the products in cholera market report.

Revenue Generation Model:

Companies are generating the revenues by manufacturing and selling the cholera diagnostic & treatment products like, ORS, antibiotics, Intravenous fluids. Most of the biotechnological firms are generating revenue mostly through manufacturing & sales of the cholera vaccine. There are many leading pharmaceutical companies which are generating revenues through the signing of agreements & collaborations with other small-scale companies in the market.

Supply Chain Analysis:

There are various department involved in the supply chain of the cholera diagnosis & treatment market such as research & development, manufacturing, sales & marketing, distributers, wholesalers & pharmacy stores as product supplied towards the consumer. The supply chain model of the cholera diagnosis & treatment market also involves the various industries like raw material supplying industries & dealers. There is a main role of the pharmacy stores & wholesalers in the supply chain of the cholera market as they directly sale the products directly to the end user i.e. patients & doctors.

Value Chain Analysis:

The value chain model of cholera market involves various stages from its development to use final use of the product, each department put efforts to maximize the product value for the customers or end users. The Global Task Force on Cholera Control (GTFCC) & WHO Support are important factors which adds values in the cholera market through support to design & implement the global strategies in sector of cholera market to increase the research & development capacities to prevent & control the cholera worldwide.

Key Market Players in the Cholera Diagnostic & Treatment Market:

Some major key players for the global cholera diagnosis & treatment Market report cover prominent players like Abbott, EuBiologics, Emergent BioSolutions, SBL Vaccines, Shantha Biotechnicsc Ltd., Orion Life Science, Biovencer Healthcare Pvt. Ltd, CIPLA, Schwitz Biotech, Sanofi, Omega, Mast Group, Benchmark scientific, Norgen Biotech, Boson In vitro Diagnostics, Pfizer Inc., GlaxoSmithKline plc, Valneva, Astellas Pharma Inc, Johnson & Johnson ltd. & other companies.

Market Drivers:

Increasing Number of Cholera Cases Is Serving As The Driving Factor In The Cholera Diagnosis & Treatment Market

The increasing prevalence of cholera is significantly driving the cholera diagnosis and treatment market. According to the World Health Organization (WHO), there has been a continuous rise in cholera cases over the past few years. In 2022, WHO reported 472,697 cases and 2,349 deaths across 44 countries, highlighting the global burden of this disease. One of the primary reasons behind the surge in cholera cases is the widespread issue of inadequate hygienic practices. Additionally, water pollution, exacerbated by industrialization and environmental changes, plays a crucial role in the spread of the disease.

These factors not only contribute to the rising number of cholera cases but also drive the demand for effective diagnostic tools and treatments. Governments and health organizations are increasingly focusing on improving water quality and sanitation, yet the persistent challenge underscores the need for advanced medical solutions. The market for cholera diagnosis and treatment is thus expanding, with ongoing research and development efforts aimed at creating more efficient and accessible healthcare options. Public awareness campaigns and investments in healthcare infrastructure are also pivotal in mitigating the impact of cholera. In summary, the combination of poor hygiene, water pollution, and environmental factors are key drivers in the growth of the cholera diagnosis and treatment market.

Amplifying Awareness Regarding Immunization Flourish the Growth Of Cholera Diagnosis & Treatment Market

Many countries reporting high numbers of cholera cases are also experiencing various natural disasters, which increase the demand for cholera vaccines worldwide. Due to a lack of resources, the world faces a shortage of these vaccines; however, in high-risk areas, people are more aware of cholera prevention and are actively seeking vaccination, thereby generating higher demand. According to WHO, since January 2023, there have been requests for 82 million oral cholera vaccines in 15 countries. The International Coordinating Group (ICG) is calling on donors, vaccine manufacturers, governments, and communities to help control and reverse the rise in cholera cases worldwide.

ICG members, including Médecins Sans Frontières, the International Federation of Red Cross and Red Crescent Societies, UNICEF, and WHO, collectively work to maintain an inventory of cholera vaccines. This increased demand highlights the need for more cholera vaccines and encourages companies to ramp up production, acting as a significant market driver in the cholera diagnosis and treatment sector.

Market Restraints:

Lack Of Enough Incentives & Support to Produce Cholera Vaccine Restrict the Growth of Cholera Diagnostic & Treatment Market

The lack of sufficient incentives and support to produce cholera vaccines significantly hampers the growth of the cholera diagnosis and treatment market. Despite the urgent need for vaccines, manufacturers often face financial and logistical challenges that deter large-scale production. According to a report by the World Health Organization (WHO), the global demand for oral cholera vaccines (OCVs) reached 82 million doses in 2023, yet production capacities fall short of meeting this demand.

One major issue is the limited financial incentives for pharmaceutical companies. Producing cholera vaccines is not as profitable as other vaccines due to the lower purchasing power of the affected countries. For example, the Gavi, the Vaccine Alliance, noted that low-income countries, which are most affected by cholera, struggle to afford the vaccines without substantial subsidies.

Furthermore, logistical challenges such as the need for cold chain storage and transportation make the distribution of vaccines to remote areas difficult and costly. The WHO's strategic advisory group of experts (SAGE) on immunization has highlighted these issues, emphasizing the need for enhanced international support and funding to address the supply gaps.

Government initiatives, such as those by the US Centers for Disease Control and Prevention (CDC), focus on improving infrastructure and funding for vaccine production, but more comprehensive global efforts are required. Without sufficient incentives and support, the cholera diagnostic and treatment market will continue to face significant growth restrictions.

Opportunity Factors:

One significant opportunity for the cholera diagnosis and treatment market lies in the development and deployment of innovative diagnostic technologies. Rapid and accurate diagnostic tools are crucial for timely intervention and treatment, which can significantly reduce the spread and impact of cholera outbreaks. According to the World Health Organization (WHO), early detection and prompt treatment are key components in controlling cholera. Traditional diagnostic methods can be slow and require specialized laboratory equipment, which may not be available in resource-limited settings.

Emerging technologies, such as rapid diagnostic tests (RDTs), offer a promising solution. These tests are portable, easy to use, and can provide results within minutes, enabling quicker response times during outbreaks. For instance, the WHO reported that the introduction of RDTs in various cholera-affected regions has led to a significant improvement in the early detection and management of the disease.

Moreover, investment in mobile health (mHealth) technologies can further enhance cholera surveillance and response. Mobile applications and digital platforms can facilitate real-time data collection and monitoring, improving outbreak prediction and management. An example of this is the "mWater" platform, which has been used in several countries to track water quality and potential cholera hotspots, aiding in rapid response and preventive measures.

The advancement and adoption of these innovative diagnostic technologies present a substantial opportunity for the cholera diagnosis and treatment market, addressing a critical need and enhancing overall disease management efforts.

Market Trends:

New solutions to diagnose & treat cholera in efficient manner:

Current diagnostic & treatment procedures having most challenges such as high cost, delayed in diagnosis, as well as treatment options have less effectivity against the drug-resistant serogroups of Vibrio cholerae. However, market is orienting towards developments & use of new solutions to treat cholera. One of the trending technologies to treat cholera is nanoparticles (NPs). They are serving as the best therapeutic solution in the treatment of cholera due to their high bioavailability & appropriate drug circulation and targeting. Generally metal based & organic nanoparticles are used for treatment of cholera.

Customer’s trend:

Focusing On Preventive Majors: People are educated & aware about the preventive majors about the cholera, most of the people are focusing towards drinking safe water, implementing the hygienic practices in their surrounding areas, one of the best prevention methods from cholera is vaccination, and hence people are demanding for the cholera vaccines in major endemic countries.

Approaching for long term safety: Most of the people are approaching long-term solutions for outbreak of cholera. Customers are orienting towards the effective and safe treatment against the cholera hence people are, hence, most of the people are orienting towards the taking vaccines as preventive majors & treating cholera as possible as by using ORS. Which is the first line & safest treatment for the cholera.

Market Competition Nature:

There is vast competition in the cholera treatment & diagnosis market, several companies are enjoying the market growth while some companies are emerging in the market. However, some key market players such as EuBiologisc, Sanofi, Pfizer Inc, Emergent BioSolutions Inc. are leading the cholera diagnostic & treatment market. Although EuBiologisc, is largest manufacturer & supplier of cholera vaccine in worldwide.

Merger & acquisitions is a strategy implementing by the companies for increasing the cholera market share such as, on 15th November 2023, Bavarian Nordic A/S (OMX: BAVA) announced their entry in agreement with the Emergent BioSolutions Inc. to acquire their marketed travel vaccine Vaxchora® against cholera & other two vaccines.

Some companies are signing agreements with each other’s, which helping to enhance the cholera diagnostic & treatment market growth, such as on 20^th march 2024, The International Vaccine Institute (IVI) announce that, they had initiated technology transfer of simplified Oral Cholera Vaccine (OCV-S) to Biological E. Limited (BE), which is India based leading vaccine manufacturing & pharmaceutical company. This agreement will help to immediate supply of vaccines in India & global as well as increase the Cholera diagnosis & treatment market.

Geography Analysis:

Africa Region Serving Higher Growth in the Cholera Market:

The cholera diagnostic and treatment market are experiencing tremendous growth, driven significantly by the increasing cholera cases in Eastern and Southern Africa. According to UNICEF, Africa is facing its worst cholera outbreak in the last decade. In 2023 alone, 230,000 cholera cases and 4,000 deaths were reported across 14 affected countries. Furthermore, as of February 2024, UNICEF states that 11 countries are facing active cholera outbreaks, while WHO has classified 6 countries as being in an "acute crisis" of cholera.

This escalating outbreak in Africa has led to a surge in demand for cholera diagnostic kits and other treatment products. Additionally, the demand for cholera vaccines in the region is increasing rapidly. These factors collectively contribute to the significant growth of the cholera diagnostic and treatment market in Africa. As the need for effective diagnostic tools and vaccines rises, the market is expected to continue expanding to address the urgent healthcare challenges posed by cholera outbreaks.

North America Region Witnessing Growth & Developing In Cholera Diagnostic & Treatment Market

The Americas region is emerging as a rapidly growing market for cholera diagnostics and treatment. Several factors contribute to this growth, including the increasing number of cholera cases in recent years. In 2022, the Americas reported the third-highest number of cholera cases globally, with 71,381 cases across two countries, according to the World Health Organization (WHO). This surge in cases has generated a higher demand for cholera diagnostic and treatment products, driving market growth.

Another key factor is the presence of major market players in the region, such as Pfizer. Pfizer is a leading provider of antibiotics and vaccines for cholera, significantly influencing the market. Additionally, Emergent BioSolutions has established a strong market position and is generating revenue by transferring marketing rights of its products to other industries. For example, on May 15, 2023, Emergent BioSolutions announced the completion of the sale of its health business to Bavarian Nordic for US$270 million. With this deal, Bavarian Nordic acquired Vaxchora®, a licensed cholera vaccine, along with other vaccines.

These developments highlight the dynamic growth of the cholera diagnostic and treatment market in the Americas, driven by rising case numbers and strategic industry moves.

Key Benefits of Global Cholera Diagnosis & Treatment Market Players:

• Global cholera diagnosis & treatment market report offers all historical as well as future insights of the cholera diagnostic & treatment market.
• It provides detail information of the cholera diagnostic & treatment market from its overview, supply chain & value chain of the cholera diagnosis & treatment products, valuable information regarding factors affecting the cholera market such as driving & a well as restraining factors, competitive analysis, and geographical analysis.
• Global cholera diagnosis & treatment market report provide the information regarding the new opportunities in the market.
• Global cholera diagnosis & treatment market report also provides the upcoming trends & competition in the market.

Global cholera diagnostic & treatment market segmentation:

By Diagnosis Type:

• Rapid diagnostic test (RDT)
• Polymerase chain reaction
• Dark Filled Microscopy

By Treatment Type:

• Vaccination
• Medication
• Fluoroquinolones
• Tetracycline
• Macrolide
• Zinc Tablets
• IV infusion
• Oral Rehydration salt (ORS)

By Administration:

• Oral rout
• Intravenous

By End Users:

• Doctors
• Patients
• Other healthcare professionals

By Regional & Country Level:

• North America
  • S.
  • Canada
• Europe
  • K.
  • France
  • Germany
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • Southeast Asia
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa